ENDOPHTHALMITIS IN OPHTHALMOLOGICAL REFERRAL CENTRE IN COLOMBIA: AETIOLOGY AND MICROBIAL RESISTANCE
- PMID: 35922145
- DOI: 10.31348/2022/19
ENDOPHTHALMITIS IN OPHTHALMOLOGICAL REFERRAL CENTRE IN COLOMBIA: AETIOLOGY AND MICROBIAL RESISTANCE
Abstract
Aims: To describe the aetiology and microbial susceptibility profile of endophthalmitis cases treated at an ophthalmological referral centre in Colombia.
Material and methods: A retrospective descriptive study was carried out with all endophthalmitis cases referred to the Fundación Oftalmológica de Santander FOSCAL (Floridablanca, Colombia) from 1 January 2012 to 31 December 2015.
Results: 121 eyes of 121 patients were evaluated. 77.7% of them were male and the mean age was 42.9 years. Five of them (4.1%) corresponded to endogenous endophthalmitis, and 116 (95.9%) to exogenous endophthalmitis. Of the latter, 66.9% were associated with trauma (almost one-half of them associated with intraocular foreign body), and 29.5% with intraocular surgery. The most common isolated microorganisms in the exogenous endophthalmitis group corresponded to methicillin-resistant and methicillin-sensitive strains of Staphylococcus epidermidis and Staphylococcus aureus, which were mostly susceptible to imipenem, vancomycin and moxifloxacin and resistant to ceftazidime.
Conclusion: Endophthalmitis is a potentially sight-threatening condition, especially in cases of inadequate treatment. Therefore, antimicrobial therapy should be guided by vitreous humour culture to assure that the causative microorganism is susceptible to the selected agent. The results of our study lead us to propose vancomycin, moxifloxacin or imipenem as first-line antimicrobial options.
Keywords: Phacoemulsification; antimicrobial susceptibility; endophthalmitis; intraocular foreign body; posterior vitrectomy.
Similar articles
-
[Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia].Biomedica. 2014 Apr;34 Suppl 1:23-33. doi: 10.1590/S0120-41572014000500004. Biomedica. 2014. PMID: 24968033 Spanish.
-
Minimum inhibitory concentrations and resistance for selected antimicrobial agents (including imipenem, linezolid and tigecycline) of bacteria obtained from eye infections.Rom J Ophthalmol. 2020 Jul-Sep;64(3):269-279. Rom J Ophthalmol. 2020. PMID: 33367160 Free PMC article.
-
Clinical presentations, risk factors and outcomes of ceftazidime-resistant Gram-negative endophthalmitis.Clin Exp Ophthalmol. 2017 Apr;45(3):254-260. doi: 10.1111/ceo.12833. Epub 2016 Oct 11. Clin Exp Ophthalmol. 2017. PMID: 27616274
-
Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review.Ophthalmology. 2014 Aug;121(8):1634-42. doi: 10.1016/j.ophtha.2014.02.001. Epub 2014 Apr 2. Ophthalmology. 2014. PMID: 24702755 Review.
-
[Endoscopy-guided 20-G vitrectomy in severe endophthalmitis: Report of 18 cases and literature review].J Fr Ophtalmol. 2015 Dec;38(10):941-9. doi: 10.1016/j.jfo.2015.07.005. Epub 2015 Nov 10. J Fr Ophtalmol. 2015. PMID: 26563835 Review. French.
Cited by
-
Safety of intracameral application of moxifloxacin and dexamethasone (Vigadexa®) after phacoemulsification surgery.Graefes Arch Clin Exp Ophthalmol. 2023 Nov;261(11):3215-3221. doi: 10.1007/s00417-023-06095-0. Epub 2023 May 25. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 37227478 Free PMC article.
-
Postoperative exogenous endophthalmitis caused by Escherichia coli: a rare case report and literature review.Future Sci OA. 2023 Apr 4;9(4):FSO850. doi: 10.2144/fsoa-2022-0076. eCollection 2023 Apr. Future Sci OA. 2023. PMID: 37090490 Free PMC article.
-
New Approaches to Overcoming Antimicrobial Resistance in Endophthalmitis.Pharmaceuticals (Basel). 2024 Mar 1;17(3):321. doi: 10.3390/ph17030321. Pharmaceuticals (Basel). 2024. PMID: 38543107 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources